Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4'-fluoro-4-(4-(2-thioxo-1-benzimidazolinyl)piperidino)butyrophenone
2. Dd 3480
1. 57648-21-2
2. Tolopelon
3. Dd-3480
4. 1-(1-(3-(p-fluorobenzoyl)propyl)-4-piperidyl)-2-benzimidazolinethione
5. 626dq7n19l
6. Timiperone (jan)
7. Timiperone [jan]
8. 4-fluoro-4-(4-(2-thioxo-1-benzimidazolinyl)piperidino)butyrophenone
9. 1-butanone, 4-(4-(2,3-dihydro-2-thioxo-1h-benzimidazol-1-yl)-1-piperidinyl)-1-(4-fluorophenyl)-
10. Timiperona
11. Timiperonum
12. Timiperone [inn:jan]
13. Timiperonum [inn-latin]
14. Timiperona [inn-spanish]
15. 1-butanone, 4-[4-(2,3-dihydro-2-thioxo-1h-benzimidazol-1-yl)-1-piperidinyl]-1-(4-fluorophenyl)-
16. Ncgc00182555-01
17. Einecs 260-880-9
18. Dd 3480
19. Unii-626dq7n19l
20. Tolopelon (tn)
21. Timiperone [mi]
22. Timiperone [inn]
23. 4'-fluoro-4-(4-(2-thioxo-1-benzimidazolinyl)piperidino)butyrophenone
24. Butyrophenone, 4'-fluoro-4-(4-(2-thioxobenzimidazol-1-yl)piperidino)-
25. Dsstox_cid_3673
26. 2-benzimidazolinethione, 1-(1-(3-(p-fluorobenzoyl)propyl)-4-piperidyl)-
27. Timiperone [mart.]
28. 1-(4-fluorophenyl)-4-[4-(2-sulfanylidene-3h-benzimidazol-1-yl)piperidin-1-yl]butan-1-one
29. Dsstox_rid_77139
30. Timiperone [who-dd]
31. Dsstox_gsid_23673
32. Schembl145839
33. Chembl2107117
34. Dtxsid9023673
35. Schembl11797177
36. Chebi:135631
37. Zinc3873392
38. Tox21_113628
39. Akos025396887
40. Ncgc00387301-01
41. 4-(4-(2,3-dihydro-2-thioxo-1h-benzimidazol-1-yl)-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone
42. Cas-57648-21-2
43. Ft-0675238
44. D02035
45. 648t212
46. Q7806745
47. 1-[1-(3-(4-fluorobenzoyl)propyl)-4-piperidyl]-2-mercaptobenzimidazole
48. 1-(4-fluorophenyl)-4-[4-(2-thioxo-2,3-dihydro-1h-benzimidazol-1-yl)piperidin-1-yl]butan-1-one
Molecular Weight | 397.5 g/mol |
---|---|
Molecular Formula | C22H24FN3OS |
XLogP3 | 4.3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Exact Mass | 397.16241173 g/mol |
Monoisotopic Mass | 397.16241173 g/mol |
Topological Polar Surface Area | 67.7 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 558 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
ABOUT THIS PAGE
55
PharmaCompass offers a list of Timiperone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Timiperone manufacturer or Timiperone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Timiperone manufacturer or Timiperone supplier.
PharmaCompass also assists you with knowing the Timiperone API Price utilized in the formulation of products. Timiperone API Price is not always fixed or binding as the Timiperone Price is obtained through a variety of data sources. The Timiperone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_3673 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_3673, including repackagers and relabelers. The FDA regulates DSSTox_CID_3673 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_3673 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_3673 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_3673 supplier is an individual or a company that provides DSSTox_CID_3673 active pharmaceutical ingredient (API) or DSSTox_CID_3673 finished formulations upon request. The DSSTox_CID_3673 suppliers may include DSSTox_CID_3673 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_3673 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The DSSTox_CID_3673 Drug Master File in Japan (DSSTox_CID_3673 JDMF) empowers DSSTox_CID_3673 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the DSSTox_CID_3673 JDMF during the approval evaluation for pharmaceutical products. At the time of DSSTox_CID_3673 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of DSSTox_CID_3673 suppliers with JDMF on PharmaCompass.
DSSTox_CID_3673 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_3673 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_3673 GMP manufacturer or DSSTox_CID_3673 GMP API supplier for your needs.
A DSSTox_CID_3673 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_3673's compliance with DSSTox_CID_3673 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_3673 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_3673 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_3673 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_3673 EP), DSSTox_CID_3673 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_3673 USP).